Cholestatic liver diseases: An era of emerging therapies.

Bile acids Cholestatic liver disease Drug therapy Nuclear receptor agonists

Journal

World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806

Informations de publication

Date de publication:
06 Jul 2019
Historique:
received: 10 01 2019
revised: 05 06 2019
accepted: 10 06 2019
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 2 8 2019
Statut: ppublish

Résumé

Recently the field of cholestasis has expanded enormously reflecting an improved understanding of the molecular mechanisms underlying bile secretion and its perturbation in chronic cholestatic disease. Novel anti-cholestatic therapeutic options have been developed for patients not favorably responding to ursodeoxycholic acid (UDCA), the current standard treatment for cholestatic liver disease. Important novel treatment targets now also include nuclear receptors involved in bile acid (BA) homoeostasis like farnesoid X receptor and G protein-coupled receptors

Identifiants

pubmed: 31367616
doi: 10.12998/wjcc.v7.i13.1571
pmc: PMC6658370
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1571-1581

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare that there is no conflict of interest regarding the publication of this paper.

Références

Science. 1999 May 21;284(5418):1362-5
pubmed: 10334992
Mol Cell. 1999 May;3(5):543-53
pubmed: 10360171
Eur J Clin Invest. 2000 Mar;30(3):203-9
pubmed: 10691996
J Hepatol. 2000 Apr;32(4):561-6
pubmed: 10782903
J Biol Chem. 2001 Aug 3;276(31):28857-65
pubmed: 11387316
J Biol Chem. 2001 Dec 14;276(50):47371-8
pubmed: 11577102
J Biol Chem. 2002 Jan 25;277(4):2908-15
pubmed: 11706036
Science. 2002 May 17;296(5571):1313-6
pubmed: 12016314
Am J Pathol. 2002 Jun;160(6):2295-307
pubmed: 12057932
Biochem Biophys Res Commun. 2002 Nov 15;298(5):714-9
pubmed: 12419312
Annu Rev Biochem. 2003;72:137-74
pubmed: 12543708
Physiol Rev. 2003 Apr;83(2):633-71
pubmed: 12663868
Gastroenterology. 2005 Feb;128(2):297-303
pubmed: 15685541
J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S90-S102
pubmed: 15758666
Hepatology. 2005 Dec;42(6):1391-8
pubmed: 16317695
Mol Pharm. 2006 May-Jun;3(3):231-51
pubmed: 16749856
J Endocrinol. 2006 Oct;191(1):197-205
pubmed: 17065403
J Hepatol. 2009 Aug;51(2):237-67
pubmed: 19501929
Hepatology. 2009 Sep;50(3):861-70
pubmed: 19582812
Hepatology. 2009 Sep;50(3):808-14
pubmed: 19585548
Gastroenterology. 2010 Feb;138(2):715-25
pubmed: 19900448
J Med Chem. 2009 Dec 24;52(24):7958-61
pubmed: 20014870
Mol Pharmacol. 2010 Oct;78(4):617-30
pubmed: 20631053
Science. 2011 Mar 25;331(6024):1621-4
pubmed: 21436455
Hepatology. 2011 Oct;54(4):1421-32
pubmed: 21735468
Hepatology. 2012 Feb;55(2):575-83
pubmed: 21953282
Hepatology. 2011 Oct;54(4):1303-12
pubmed: 22006858
PLoS One. 2011;6(10):e25637
pubmed: 22046243
J Hepatol. 2012 Jul;57(1):133-40
pubmed: 22414767
Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G322-7
pubmed: 23238937
J Hepatol. 2013 Jun;58(6):1201-8
pubmed: 23369794
Clin Liver Dis. 2013 May;17(2):161-89
pubmed: 23540496
Dig Liver Dis. 2014 Apr;46(4):302-12
pubmed: 24411485
Curr Opin Gastroenterol. 2014 May;30(3):279-86
pubmed: 24625898
Cancer Res. 2014 Jun 15;74(12):3306-16
pubmed: 24728076
Hepatol Res. 2015 Jan;45(1):48-58
pubmed: 24934524
Hepatology. 2014 Nov;60(5):1593-606
pubmed: 24995693
Gastroenterology. 2014 Dec;147(6):1417-28
pubmed: 25194674
J Hepatol. 2015 Mar;62(3):720-33
pubmed: 25450203
Gastroenterology. 2015 Apr;148(4):751-61.e8
pubmed: 25500425
Am J Pathol. 2015 Feb;185(2):409-19
pubmed: 25592258
Hepatology. 2015 Aug;62(2):635-43
pubmed: 25678132
Am J Gastroenterol. 2015 Mar;110(3):423-31
pubmed: 25732417
J Hepatol. 2015 Apr;62(1 Suppl):S25-37
pubmed: 25920087
Gastroenterology. 2015 Dec;149(7):1804-1812.e4
pubmed: 26261009
Hepatology. 2016 Mar;63(3):914-29
pubmed: 26418580
Aliment Pharmacol Ther. 2016 Jan;43(2):303-10
pubmed: 26527417
J Hepatol. 2016 Mar;64(3):674-81
pubmed: 26529078
Aliment Pharmacol Ther. 2016 Jan;43(2):283-93
pubmed: 26559762
Gastroenterology. 2016 May;150(5):1147-1159.e5
pubmed: 26874076
N Engl J Med. 2016 Aug 18;375(7):631-43
pubmed: 27532829
Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):25-31
pubmed: 27586800
Lancet. 2017 Mar 18;389(10074):1114-1123
pubmed: 28187915
Lancet. 1987 Apr 11;1(8537):834-6
pubmed: 2882236
World J Gastroenterol. 2017 Aug 7;23(29):5257-5265
pubmed: 28839426
Hepatol Commun. 2018 Aug 30;2(9):1037-1050
pubmed: 30202819
Gastroenterology. 1980 Jul;79(1):82-9
pubmed: 7380227
Mol Endocrinol. 1995 Jan;9(1):72-85
pubmed: 7760852
N Engl J Med. 1998 Oct 22;339(17):1217-27
pubmed: 9780343

Auteurs

Hrishikesh Samant (H)

Division of Gastroenterology and Hepatology, Department of medicine, LSU health, Shreveport, LA 71103, United States.

Wuttiporn Manatsathit (W)

Division of Gastroenterology and Hepatology, University of Nebraska, Omaha, NE 68194, United States.

David Dies (D)

John C McDonald Transplant Center, Willis Knighton Medical Center, Shreveport, LA 71103, United States.

Hosein Shokouh-Amiri (H)

John C McDonald Transplant Center, Willis Knighton Medical Center, Shreveport, LA 71103, United States.

Gazi Zibari (G)

John C McDonald Transplant Center, Willis Knighton Medical Center, Shreveport, LA 71103, United States.

Moheb Boktor (M)

Division of Gastroenterology and Hepatology, Department of medicine, LSU health, Shreveport, LA 71103, United States.

Jonathan Steve Alexander (JS)

Department of Molecular and Cellular Physiology, Louisiana State University, School of Medicine, Shreveport, LA 71103, United States. jalexa@lsuhsc.edu.

Classifications MeSH